ICU
SeaStar Medical Holding Corp
NASDAQ · Healthcare · Biotechnology · US
$2.07
+3.48%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$2.04
From 52W high−60.20%
Volume58705.00
Market cap$11.00M
P/E (TTM)—
P/S (TTM)6.4x
Div yield—
Key dataNov 4, 2026
Open
$2.04
From 52W high
−60.20%
Volume
58705.00
Market cap
$11.00M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
34.1
MomentumView details →
1D Return
+3.48%
YTD Return
−13.75%
SummaryUpdated Jun 1, 2026
SeaStar Medical Holding Corporation (NASDAQ:ICU) is a Denver-based medical device company that went public in March 2021. The company specializes in developing extracorporeal therapies designed to treat hyperinflammation and cytokine storm in critically ill patients. SeaStar focuses on targeting the cellular mechanisms that drive systemic inflammation, which can cause direct tissue damage and trigger cascading immune responses that worsen patient outcomes in intensive care settings.
Similar companies
Latest newsMore news →
SeaStar Medical Holding Corp announced that it will report third-quarter 2026 financial results after market close on November 11, 2026, and host a webcast and conference call.4h agoThe FDA determined that SeaStar Medical's QUELIMMUNE Pediatric SAVE Surveillance Registry fulfilled the post-approval study requirements in the device's original Humanitarian Device Exemption approval.1d ago